# CEPHALEXIN
> **ANDA210221** · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2019-03-26
## Drug
- **FDA Application Number:** ANDA210221
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CEPHALEXIN
- **Generic name:** CEPHALEXIN
- **Active ingredients:** CEPHALEXIN
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALKEM LABS LTD
- **Manufacturer:** Ascend Laboratories, LLC
- **First approval:** 2019-03-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210221)
---
*MORVS · CC0 1.0*